Cargando…
(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
BACKGROUND: Glucose metabolism has been suggested as a therapeutic target in ovarian clear cell carcinoma (CCC). We attempted to clarify (18)F-FDG PET/CT-based metabolic metrics in the recurrent ovarian CCC patients and their prognostic values. METHODS: Quantitative metabolic parameters included max...
Autores principales: | Ye, Shuang, Liu, Shuai, Xiang, Libing, Wu, Xiaohua, Yang, Huijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417247/ https://www.ncbi.nlm.nih.gov/pubmed/30866858 http://dx.doi.org/10.1186/s12885-019-5441-7 |
Ejemplares similares
-
The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2020) -
Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013) -
Preoperative [(18)F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer
por: Chung, Hyun Hoon, et al.
Publicado: (2012) -
Prognostic Values of TIGAR Expression and (18)F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
por: Wang, Xiaoyan, et al.
Publicado: (2020) -
To Enhance or Not to Enhance? The Role of Contrast Medium (18)F-FDG PET/CT in Recurrent Ovarian Carcinomas
por: Massollo, Michela, et al.
Publicado: (2021)